6533b854fe1ef96bd12aec42
RESEARCH PRODUCT
The war against coronavirus disease 19 through the eyes of cancer physician: An Italian and Indian young medical oncologist's perspective
Maria La MantiaVenkata Pradeep Babu Koyyalasubject
medicine.medical_specialty2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Perspective (graphical)CancerDiseasemedicine.disease_causemedicine.diseaseSpanish Civil Waroncology covid-19OncologyFamily medicinePediatrics Perinatology and Child HealthmedicinebusinessCoronavirusdescription
These are unprecedented times, we are living in with an outbreak of a novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (CoV-2), or CoV Disease 19 (COVID-19). By April 20th, as per the World Health Organization Data, COVID-19 as a pandemic has caused 2,407,414 cases, and 165,073 confirmed deaths in 213 different countries worldwide. Elderly patients and those with comorbid illnesses with COVID-19 infection have poor outcomes. Cancer patients are immunosuppressed, and at an increased risk of COVID-19 infection and have worse outcomes as compared to the general population. The mortality rate of COVID-19 among oncology patients is about 20%.[1] Young oncologists are guided by the national and international cancer societies through guidelines that are adapted during this pandemic for the safety of patients and physicians.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2020-05-01 |